BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25239263)

  • 1. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.
    Zhang MY; Keel SB; Walsh T; Lee MK; Gulsuner S; Watts AC; Pritchard CC; Salipante SJ; Jeng MR; Hofmann I; Williams DA; Fleming MD; Abkowitz JL; King MC; Shimamura A
    Haematologica; 2015 Jan; 100(1):42-8. PubMed ID: 25239263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.
    Keel SB; Scott A; Sanchez-Bonilla M; Ho PA; Gulsuner S; Pritchard CC; Abkowitz JL; King MC; Walsh T; Shimamura A
    Haematologica; 2016 Nov; 101(11):1343-1350. PubMed ID: 27418648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and laboratory evaluation of patients with suspected hypocellular marrow failure.
    Keel S; Geddis A
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):134-142. PubMed ID: 34889426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
    Nováková M; Žaliová M; Suková M; Wlodarski M; Janda A; Froňková E; Campr V; Lejhancová K; Zapletal O; Pospíšilová D; Černá Z; Kuhn T; Švec P; Pelková V; Zemanová Z; Kerndrup G; van den Heuvel-Eibrink M; van der Velden V; Niemeyer C; Kalina T; Trka J; Starý J; Hrušák O; Mejstříková E
    Haematologica; 2016 Jun; 101(6):707-16. PubMed ID: 27013649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients.
    Bluteau O; Sebert M; Leblanc T; Peffault de Latour R; Quentin S; Lainey E; Hernandez L; Dalle JH; Sicre de Fontbrune F; Lengline E; Itzykson R; Clappier E; Boissel N; Vasquez N; Da Costa M; Masliah-Planchon J; Cuccuini W; Raimbault A; De Jaegere L; Adès L; Fenaux P; Maury S; Schmitt C; Muller M; Domenech C; Blin N; Bruno B; Pellier I; Hunault M; Blanche S; Petit A; Leverger G; Michel G; Bertrand Y; Baruchel A; Socié G; Soulier J
    Blood; 2018 Feb; 131(7):717-732. PubMed ID: 29146883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance.
    Fernandez-Pol S; Ma L; Ohgami RS; Arber DA
    Mod Pathol; 2016 Sep; 29(9):996-1003. PubMed ID: 27255165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
    Elghetany MT; Patnaik MM; Khoury JD
    Leuk Res; 2024 Feb; 137():107441. PubMed ID: 38301422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of somatic panels for the detection of haematopoietic transformation in children and young adults with leukaemia predisposition syndromes and with acquired cytopenias.
    Noy-Lotan S; Krasnov T; Dgany O; Jeison M; Yanir AD; Gilad O; Toledano H; Barzilai-Birenboim S; Yacobovich J; Izraeli S; Tamary H; Steinberg-Shemer O
    Br J Haematol; 2021 May; 193(3):570-580. PubMed ID: 33368157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.
    Bräuninger A; Blau W; Kunze K; Desch AK; Brobeil A; Tur MK; Etschmann B; Günther U; Körholz D; Schliesser G; Käbisch A; Kiehl M; Rummel M; Gattenlöhner S
    J Mol Diagn; 2018 May; 20(3):344-354. PubMed ID: 29471115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
    Wang SA; Pozdnyakova O; Jorgensen JL; Medeiros LJ; Stachurski D; Anderson M; Raza A; Woda BA
    Haematologica; 2009 Jan; 94(1):29-37. PubMed ID: 19001281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When to worry about inherited bone marrow failure and myeloid malignancy predisposition syndromes in the setting of a hypocellular marrow.
    Narla A
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):153-156. PubMed ID: 34889379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.
    Tamary H; Nishri D; Yacobovich J; Zilber R; Dgany O; Krasnov T; Aviner S; Stepensky P; Ravel-Vilk S; Bitan M; Kaplinsky C; Ben Barak A; Elhasid R; Kapelusnik J; Koren A; Levin C; Attias D; Laor R; Yaniv I; Rosenberg PS; Alter BP
    Haematologica; 2010 Aug; 95(8):1300-7. PubMed ID: 20435624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
    Schratz KE; DeZern AE
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):333-356. PubMed ID: 32089214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure.
    DeZern AE; Sekeres MA
    Oncologist; 2014 Jul; 19(7):735-45. PubMed ID: 24899643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood Myelodysplastic Syndrome.
    Chisholm KM; Bohling SD
    Clin Lab Med; 2023 Dec; 43(4):639-655. PubMed ID: 37865508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis, genetics, and management of inherited bone marrow failure syndromes.
    Alter BP
    Hematology Am Soc Hematol Educ Program; 2007; ():29-39. PubMed ID: 18024606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.